Founded in 1999, Apple Tree Partners (ATP) is a leader in life sciences venture capital, with $2.9 billion in committed capital and offices in New York, South San Francisco, and Cambridge, MA.

We create and invest in companies starting at various stages, from pre-IP ideas to asset spinouts, from seed stage through IPO and beyond.

The core of our strategy is to provide flexible capital and access to a world-class team, to build sustainable, research-driven enterprises that improve human lives.